Hasil Filter

11778

Total database: 17430
Struktur (SMILES)
8554 (72.6%)
Target
6383 (54.2%)
Genomik
96 (0.8%)
Referensi
11778 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (11778)

Halaman 220 / 236
Topotecan Approved DB01030
small molecule | CAS: 123948-87-8

An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA topoisomerases, type I.

Kategori:
AlkaloidsAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +21
Target Protein:
DNA topoisomerase 1DNADNA topoisomerase I, mitochondrial
Waktu Paruh2-3 hours
Vol. Distribusi-
Klirens-
Genetik -
Topsalysin DB05160
small molecule | CAS: 917121-25-6

Topsalysin is being developed for the treatment of localized prostate cancer and also benign prostatic hyperplasia. Topsalysin is delivered locally to the prostate under ultrasound guidance.

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsMembrane Proteins +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Toralizumab DB16384
biotech | CAS: 252662-47-8

Toralizumab is under investigation in clinical trial NCT03605927 (CD40-L Blockade for Prevention of Acute Graft-versus-host Disease).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Torapsel DB13057
biotech | CAS: 204658-47-9

Torapsel has been used in trials studying the prevention of Ischemia Reperfusion Injury.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Torasemide Approved DB00214
small molecule | CAS: 56211-40-6

Torasemide is a high-ceiling loop diuretic.[A174463] Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent.[A319] Torasemide was first approved for clinical use by the FDA in 1993.[L5257]

Kategori:
Antihypertensive AgentsAntihypertensive Agents Indicated for HypertensionCardiovascular Agents +21
Target Protein:
Solute carrier family 12 member 2Solute carrier family 12 member 1
Waktu ParuhThe average half-li…
Vol. DistribusiThe volume of distr…
KlirensThe clearance rate …
Genetik -
Torcetrapib DB06281
small molecule | CAS: 262352-17-0

Torcetrapib (CP-529414, Pfizer) was developed to treat hypercholesterolemia but its development was halted in 2006 when phase III studies showed excessive mortality in the treatment group receiving a combination of atorvastatin and the study drug.

Kategori:
Anticholesteremic AgentsBlood PressureCholesterol Ester Transfer Proteins +3
Target Protein:
Cholesteryl ester transfer protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Toremifene Approved DB00539
small molecule | CAS: 89778-26-7

Toremifene is a selective estrogen receptor modulator (SERM) and a nonsteroidal antiestrogen used to treat estrogen receptor positive breast cancer.[A256923] Like [tamoxifen], toremifene is part of the first-generation triphenylethylene derivative chemical cl…

Kategori:
Anti-EstrogensAntineoplastic AgentsAntineoplastic Agents, Hormonal +23
Target Protein:
Estrogen receptorSex hormone-binding globulin
Waktu Paruh5 days
Vol. Distribusi* 580 L
Klirens* 5 L/h
Genetik -
TORL-2-307 DB18376
biotech

TORL-2307 is a humanized immunoglobulin G1 (IgG1) monoclonal antibody (mAb) directed against claudin 18.2 (CLDN18.2) being investigated for the treatment of gastric and pancreatic cancer.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Torudokimab DB16671
biotech | CAS: 2241728-76-5

Torudokimab is under investigation in clinical trial NCT03831191 (A Study of LY3375880 in Adults With Moderate-to-severe Atopic Dermatitis).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tosatoxumab DB16557
biotech | CAS: 1374419-41-6

Tosatoxumab is a fully-human monoclonal antibody (IgG1?) targeting the Staphylococcus aureus alpha-toxin or the S. aureus alpha-hemolysin[A191829, L31568, L31573] and thereby preserving human immune cells by protecting against destruction of host cells mediat…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tosedostat DB11781
small molecule | CAS: 238750-77-1

Tosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. Tosedostat is an inhibitor of the M1 family of aminopeptidases, in particular PuSA, and …

Kategori:
AminesAmino AcidsAmino Acids, Peptides, and Proteins +3
Target Protein:
Puromycin-sensitive aminopeptidaseLeukotriene A-4 hydrolase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 192391-48-3

Deskripsi belum tersedia.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntigens, CD20 +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tosyl-D-Proline DB02752
small molecule

Deskripsi belum tersedia.

Target Protein:
Thymidylate synthaseThymidylate synthase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tosylchloramide DB14708
small molecule | CAS: 144-86-5

Tosylchloramide, also known as chloramine-T, is a chlorinated and deprotonated sulfonamide used as a mild disinfectant. It is not stable in the water dissolved form.

Kategori:
AminesAnti-Infective AgentsAnti-Infective Agents, Local +14
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tovetumab DB12609
biotech | CAS: 1243266-04-7

Tovetumab has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tovinontrine DB16193
small molecule | CAS: 2062661-53-2

Tovinontrine is an orally administered, highly selective phosphodiesterase 9 (PDE9) small molecule inhibitor. Tovinontrine is under investigation in clinical trial NCT04474314 (A Study of IMR-687 in Subjects With Sickle Cell Disease).

Target Protein:
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tovorafenib Approved DB15266
small molecule | CAS: 1096708-71-2

Tovorafenib is a selective type II RAF kinase inhibitor with anti-tumour activity.[A263597] It was granted accelerated approval by the FDA, making it the first FDA approval of a systemic therapy for the treatment of pediatric low-grade glioma, with BRAF rearr…

Kategori:
B-Raf serine-threonine kinase (BRAF) inhibitorsBCRP/ABCG2 InhibitorsCytochrome P-450 CYP1A2 Inducers +31
Target Protein:
RAF proto-oncogene serine/threonine-protein kinaseSerine/threonine-protein kinase A-RafSerine/threonine-protein kinase B-raf
Waktu ParuhTovorafenib termina…
Vol. DistribusiTovorafenib apparen…
KlirensThe apparent cleara…
Genetik -
Toyocamycin DB13916
small molecule | CAS: 606-58-6

4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.

Kategori:
Antibiotics, AntineoplasticAntimetabolitesAntineoplastic Agents +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tozadenant DB12203
small molecule | CAS: 870070-55-6

Tozadenant has been investigated for the basic science of Cocaine Dependence.

Kategori:
Heterocyclic Compounds, Fused-RingThiazoles
Target Protein:
Adenosine receptor A2a
Waktu ParuhFollowing the oral …
Vol. Distribusi-
Klirens-
Genetik -
Tozinameran Approved DB15696
biotech | CAS: 2417899-77-3

The Pfizer-BioNTech COVID-19 vaccine (also known as BNT162b2, Tozinameran, and Comirnaty), is one of four advanced mRNA-based vaccines developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002,L15007,L36025] Comirnaty is a nu…

Kategori:
Amino Acids, Peptides, and ProteinsAntigensBiological Factors +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tozuleristide DB15375
biotech | CAS: 1673565-40-6

Tozuleristide is under investigation in clinical trial NCT02464332 (Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery).

Kategori:
Arthropod VenomsBiological FactorsComplex Mixtures +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TP-1287 DB18104
small molecule | CAS: 2044686-42-0

Deskripsi belum tersedia.

Target Protein:
Cyclin-dependent kinase 9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TP-252 DB17912
small molecule | CAS: 1841444-50-5

TP-252 consists of magnesium L-lysinate bis-eicosapentaenoate, an ionizable salt of eicosapentaenoic acid (EPA), currently being investigated to treat familial adenomatous polyposis.[A259956]

Kategori:
Dietary FatsDietary Fats, UnsaturatedEicosanoids +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TP-271 DB15040
small molecule | CAS: 1207284-17-0

TP-271 is under investigation in clinical trial NCT02724085 (A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271).

Kategori:
Naphthacenes
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TPCA-1 DB17058
small molecule | CAS: 507475-17-4

TPCA-1 is a selective inhibitor of human I?B kinase 2 (IKK-2).[A253152]

Kategori:
Enzyme InhibitorsProtein Kinase InhibitorsSulfur Compounds
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TPI-287 DB17168
small molecule | CAS: 849213-15-6

Deskripsi belum tersedia.

Kategori:
CyclodecanesCycloparaffinsDiterpenes +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TPI-ASM8 DB05572
small molecule

TPI-ASM8 was under investigation in clinical trials NCT00822861, NCT01158898, NCT00402948, and NCT00550797, all for the treatment of Asthma.

Kategori:
Antisense OligonucleotidesNucleic Acids, Nucleotides, and NucleosidesNucleotides +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TPIV 200 DB17318
biotech

TPIV 200 is a vaccine consisting of proteins from the folate receptor alpha mixed with Granulocyte-macrophage colony-stimulating factor (GM-CSF).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TPMPA DB16754
small molecule | CAS: 182485-36-5

TPMPA ((1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid) is a selective antagonist of GABA<sub>C</sub> receptors (also known as GABA-? or GABA<sub>A-?</sub> receptors).[A245303] GABA<sub>C</sub> receptors are found primarily in the retina, although they…

Target Protein:
Gamma-aminobutyric acid receptor subunit rho-1Gamma-aminobutyric acid receptor subunit rho-2Gamma-aminobutyric acid receptor subunit rho-3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TQS-168 DB18108
small molecule | CAS: 49671-76-3

Deskripsi belum tersedia.

Kategori:
Blood Glucose Lowering AgentsHeterocyclic Compounds, Fused-Ring
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trabectedin Approved DB05109
small molecule | CAS: 114899-77-3

Trabectedin, also referred as ET-743 during its development, is a marine-derived antitumor agent discovered in the Carribean tunicate _Ecteinascidia turbinata_ and now produced synthetically. Trabectedin has a unique mechanism of action. It binds to the minor…

Kategori:
Agents Causing Muscle ToxicityAlkylating ActivityAlkylating Drugs +24
Target Protein:
DNA
Waktu Paruh33-50 hours
Vol. Distribusi-
Klirens-
Genetik -
Trabedersen DB05697
biotech | CAS: 925681-61-4

Deskripsi belum tersedia.

Kategori:
Antineoplastic AgentsNucleic Acids, Nucleotides, and NucleosidesNucleotides +3
Target Protein:
Transforming growth factor beta-2 proprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trabodenoson DB13122
small molecule | CAS: 871108-05-3

Trabodenoson has been used in trials studying the treatment of Ocular Hypertension (OHT) and Primary Open-Angle Glaucoma (POAG).

Kategori:
Adenosine A receptor agonistsAdenosine A1 Receptor AgonistsAnions +9
Target Protein:
Adenosine receptor A1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tradipitant DB12580
small molecule | CAS: 622370-35-8

Tradipitant has been used in trials studying the treatment and prevention of Eczema, Pruritus, Gastroparesis, Chronic Pruritus, and Atopic Dermatitis, among others.

Target Protein:
Substance-P receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tragacanth Approved DB10667
biotech | CAS: 9000-65-1

Tragacanth allergenic extract is used in allergenic testing.

Kategori:
Biological ProductsBiopolymersCarbohydrates +16
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 1808916-28-0

Tralesinidase alfa is a chimeric fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. It is being investigated for the treatment of mucopolysaccharidosis type IIIB (MPS IIIB), also known as Sanfilippo syndrome…

Kategori:
Amino Acids, Peptides, and Proteinsbeta-N-AcetylhexosaminidasesBiological Factors +12
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tralokinumab Approved DB12169
biotech | CAS: 1044515-88-9

Atopic dermatitis (AD) is an inflammatory skin disorder that causes skin inflammation, skin barrier dysfunction, and chronic pruritus.[A242432] It is estimated to affect up to 20% of adults and children worldwide, and is frequently associated with other atopi…

Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAmino Acids, Peptides, and ProteinsAntibodies +9
Target Protein:
Interleukin-13
Waktu ParuhThe half-life of tr…
Vol. DistribusiThe volume of distr…
KlirensThe clearance of tr…
Genetik -
Tramadol Approved DB00193
small molecule | CAS: 27203-92-5

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to [codeine] and [morphine]. Due to its good tolerability profile and multimodal mechanism of action, tramadol is gen…

Kategori:
Agents producing tachycardiaAgents that reduce seizure thresholdAlcohols +33
Target Protein:
Mu-type opioid receptorSodium-dependent noradrenaline transporterSodium-dependent serotonin transporter +12
Waktu ParuhTramadol reported a…
Vol. DistribusiThe volume of distr…
KlirensIn clinical trials,…
Genetik -
Tramazoline DB13064
small molecule | CAS: 1082-57-1

Tramazoline is under investigation in clinical trial NCT01601509 (Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and).

Kategori:
Agents producing tachycardiaAgents that produce hypertensionAutonomic Agents +4
Target Protein:
Alpha-2A adrenergic receptorAlpha-2B adrenergic receptorAlpha-2C adrenergic receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Trametes versicolor fruiting body is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trametinib Approved DB08911
small molecule | CAS: 871700-17-3

Trametinib is an orally bioavailable mitogen-activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 inhibitor.[A258298,A258293] It was first approved by the FDA in May 2013 for the treatment of melanoma.[A258298] It was later approved by Health Can…

Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsCytochrome P-450 CYP2C8 Inhibitors +20
Target Protein:
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
Waktu ParuhThe estimated elimi…
Vol. DistribusiThe apparent volume…
KlirensThe apparent cleara…
Genetik -
Tramiprosate DB06527
small molecule | CAS: 3687-18-1

Deskripsi belum tersedia.

Kategori:
AlkanesAlkanesulfonic AcidsAnticonvulsants +10
Target Protein:
Amyloid-beta precursor protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trandolapril Approved DB00519
small molecule | CAS: 87679-37-6

Trandolapril is a non-sulhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to its biologically active diacid form, trandolaprilat, in the liver. Trandolaprilat inhibits ACE, the enzyme res…

Kategori:
ACE Inhibitors and Calcium Channel BlockersAgents Acting on the Renin-Angiotensin SystemAgents causing angioedema +9
Target Protein:
Angiotensin-converting enzyme
Waktu ParuhThe elimination hal…
Vol. Distribusi* 18 L
Klirens* 52 L/h [After app…
Genetik -
Trandolaprilat DB14209
small molecule | CAS: 87679-71-8

The active metabolite of the prodrug [Trandolapril].

Kategori:
Agents Acting on the Renin-Angiotensin SystemAgents causing angioedemaAngiotensin-Converting Enzyme Inhibitors +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tranexamic acid Approved DB00302
small molecule | CAS: 1197-18-8

Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to [aminocaproic acid] but is approximately 10-fold more potent.[L31883] It was …

Kategori:
Acids, CarbocyclicAmino AcidsAmino Acids, Peptides, and Proteins +10
Target Protein:
Plasminogen
Waktu ParuhFollowing intraveno…
Vol. DistribusiThe initial volume …
KlirensThe plasma clearanc…
Genetik -
Tranilast DB07615
small molecule | CAS: 53902-12-8

Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. In 1982, it was approved in Japan and South Korea for the management of bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatmen…

Kategori:
Acids, CarbocyclicAgents causing hyperkalemiaAminobenzoates +23
Target Protein:
Steryl-sulfataseHistamine H1 receptorHematopoietic prostaglandin D synthase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
Immunoglobulin heavy constant gamma 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
Prothrombin
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
Urokinase-type plasminogen activator
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 3465-72-3

Deskripsi belum tersedia.

Kategori:
Acids, AcyclicAcrylatesImidazoles
Target Protein:
Urocanate hydratase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 10951–11000 dari 11778
Sebelumnya Halaman 220 / 236 Berikutnya